Clinical trial Recruiting at 10 sites Observational Ages 6 to 23

Global assessment of keratoconus prevalence in children and adolescents

Official title: The K-Map Study, Global Prevalence of KC

Run by University Hospital, Geneva · NCT03115710 · Data updated 2026-11-12

This study is trying to find out how common keratoconus is in kids and teens around the world by using special eye imaging techniques.

More Keratoconus trials

Quick facts

Study typeObservational
Ages6 Years to 23 Years
SexAll
Enrollment20000 (estimated)
SponsorUniversity Hospital, Geneva
Academic / other
Locations12 sites (Los Angeles, California and 11 other locations)
StatusRecruiting
StartedDecember 28, 2015
Main results expectedFebruary 1, 2030
Study endsFebruary 1, 2030
Registry record updatedAugust 11, 2025
Trial IDNCT03115710 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are children and adolescents aged 6 to 20 years who are attending medical appointments for non-ophthalmologic reasons.

Probably not a fit

Patients with preexisting ocular diseases or conditions, as well as those who are pregnant or breastfeeding, may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate the prevalence of keratoconus in children and adolescents across various global regions using advanced tomographic imaging techniques. By conducting bilateral corneal tomography examinations on participants aged 6 to 20 years who are visiting for non-ophthalmologic reasons, the study seeks to determine if the actual prevalence of keratoconus is higher than previously reported. The research will take place in multiple cities across North America, South America, Asia, and Europe, providing a comprehensive view of the condition's prevalence worldwide.

Why it matters

Potential benefit: If successful, this study could lead to improved understanding and awareness of keratoconus prevalence, potentially influencing early detection and treatment strategies.

How similar studies have gone: While there have been studies on keratoconus, this approach of assessing global prevalence using modern imaging techniques is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Male or female, 6-23 years of age.
* Subjects seen for a non-ophthalmic appointment
* Provide signed and dated patient consent form (signed by parents / legal guardians).
* Willing to comply with all study procedures and be available for the duration of the study

Exclusion Criteria:

* Patients with a preexisting ocular disease / condition
* Pregnancy or breastfeeding

Where it's running

  • USC Roski Eye Institute
    Los Angeles, California, United States
    Recruiting
  • Eye Hospital of Wenzhou Medical College
    Wenzhou, China
    Recruiting
  • Zagreb, Croatia Recruiting
  • Alexandria, Egypt Recruiting
  • Homburg, Germany Recruiting
  • Isfahan, Iran Recruiting
Show 6 more locations
  • Amman, Jordan Recruiting
  • Monterrey, Mexico Recruiting
  • Lima, Peru Recruiting
  • Bukhara, Uzbekistan Recruiting
  • Ufa Eye Research Intitute
    Ufa, Russia
    Completed
  • King Saud University
    Riyadh, Saudi Arabia
    Completed

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.